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Abstract
Background: The purpose of this study was to evaluate the prevalence of syncope induced by head-up 
tilt test (HUTT) and the type of positive vasovagal response to the orthostatic stress in a relationship to 
the estimated phase of menstrual cycle (follicular phase, luteal phase) or menopause.
Methods: We observed a cohort of 500 women at age 13–89 years (median of age 37.5), referred to 
HUTT. Phase of the menstrual cycle was determined on the basis of the usual length of menstrual cycle 
and the day of the cycle at the time of the study. We assumed that the length of the luteal phase is constant 
and it is 14 days.
Results: In premenopausal patients, the occurrence of the mixed and cardioinhibitory response was sig-
nificantly more frequent in comparison to postmenopausal women (48.8 vs. 35.1% and 19.7 vs. 12.4%, 
respectively; p < 0.00001), while the occurrence of the vasodepressive one was significantly less frequent 
(7.3% vs. 28.6%; p < 0.00001) in that group of patients. Women in follicular phase presented vasodepres-
sive response during HUTT more often than woman in the luteal phase (10.0% vs. 4.1%, p < 0.00001).
Conclusions: Among women referred for HUTT, the prevalence of the vasovagal syndrome did not 
differ between those that were pre- and post-menopausal. Higher incidence of vasodepressive reaction in 
postmenopausal women was observed. Among the premenopausal women, the vasodepressive type of vas-
ovagal syndrome occurred more often in follicular then in luteal phase. (Cardiol J 2017; 24, 5: 523–529)
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Introduction
A woman’s body is subject to continuous but 
changing influence from the endocrine system 
throughout her life. After puberty, estrogen and 
progesterone levels rise and fall alternately ac-
cording to the phase of the menstrual cycle. Later, 
during the perimenopausal period, estrogen and 
progesterone levels begin to fall with synchronous 
increase in gonadotropin (FSH and LH) levels [1]. 
Numerous studies have confirmed that female 
hormones influence the cardiovascular system. 
Estrogen receptors are present on the endothe-
lial cells and vascular smooth muscles, and are 
involved in the regulation of vascular resistance 
[2–4]. Female hormones also influence the sensi-
tivity of adrenergic receptors in the sympathetic 
nervous system, as well as plasma volume and skin 
blood flow [5–7]. Moreover, they may influence en-
dothelial function, leading to abnormal vasodilation 
of peripheral arteries during vasovagal syncope in 
response to orthostatic stress.
Given the role female sex hormones play in the 
cardiovascular system, it is plausible that they also 
modulate the reflex responses which are responsi-
ble for the occurrence of vasovagal syncope. The 
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mechanism of reflex syncope is based on the fact 
that orthostatic stress, emotional stimuli and pain 
can induce transient dysfunction of the autonomic 
nervous system, leading to a drop in blood pres-
sure, bradycardia and finally, loss of consciousness. 
Paradoxically, peripheral vasodilation caused by 
endothelial dysfunction may also play a key role 
in inappropriate, excessive hypotension during 
orthostatic stress in individuals with vasovagal 
syndrome (VVS) [8].
The incidence of vasovagal syncope is higher 
in women than in men [9, 10]. There are some pub-
lications revealing that results of the head-up tilt 
test (HUTT) are not influenced by menstrual cycle 
phase [11]. The HUTT has been used to diagnose 
reflex syncope for 30 years, but today, in the light 
of the results of the ISSUE-3 placebo-controlled 
study, practice has changed and is directed in fa-
vor of risk stratification than diagnosis. A positive 
HUTT indicates susceptibility to hypotension and 
vasodepression; it may also indicate that a patient 
will benefit less from pacing therapy, because of 
a higher risk of syncope recurrence [12].
The purpose of this study was to evaluate the 
prevalence of syncope induced by HUTT and the 
type of positive vasovagal response to the orthos-
tatic stress in a relationship to the estimated phase 
of menstrual cycle (follicular phase, luteal phase) 
or menopause.
Methods
Participants were recruited consecutively 
from a population of 1,275 patients with recurrent 
syncopal events. The sample consisted of 500 
women aged 13–89 years (median age 37.5 years, 
interquartile range [IQR] 23–59) with the history 
of faints with probable vasovagal etiology, who had 
been referred for to the Syncope Unit of Department 
of Coronary Disease and Heart Failure at the Jag-
iellonian University Medical College, John Paul II 
Hospital in Krakow for further investigation. 
Patients with underlying cardiovascular disease, 
which might cause episodes of syncope, and pa-
tients with symptomatic orthostatic hypotension 
due to cardiovascular or neurological diseases were 
excluded from the study.
Informed consent was obtained from all indi-
vidual participants included in the study. The study 
was conducted in accordance with the Declaration 
of Helsinki and approved by the Bioethical Com-
mittee at Jagiellonian University in Krakow.
After an initial assessment, all women under-
went the HUTT, which was administered accord-
ing to the guidelines of the European Society of 
Cardiology [13]. The initial evaluation included 
medical history, clinical examination, measure-
ment of blood pressure (supine and standing) and 
electrocardiogram [13].
The HUTT was administered in a silent, slight-
ly darkened room maintained at a constant tempera-
ture. Interfering external stimuli (acoustic, visual 
and other) were excluded during the test. The test 
was administered according to one of two randomly 
selected protocols: the Westminster protocol (pas-
sive phase of 60-degree tilt lasting for 45 min) or 
Italian protocol (passive tilting phase of 60-degree 
tilt lasting for 20 min). Where the passive phase 
produced a negative results it was fallowed by 
sublingual administration of 0.4 mg nitroglycerine 
(NTG)-provocation phase — which lasted for anoth-
er 20 min in Westminster protocol and for another 
15 min in Italian protocol. The HUTT continued 
until syncope occurred or until the protocol was 
completed [13]. During the HUTT, an electrocardio-
gram (ECG) recording was made and beat-to-beat 
blood pressure was monitored continuously using 
a validated, non-invasive method (Nexfin, BMEYE, 
The Netherlands).
The result of the HUTT was classified as 
positive if the test induced reflex hypotonia and/or 
bradycardia with concomitant syncope, similar to 
spontaneous syncope. Intensive prodromal symp-
toms without syncope provocation were classified 
as a doubtful test result [12]. The VASIS (The 
Vasovagal Syncope International Study) classifica-
tion was used to classify vasovagal responses to tilt 
testing, based on heart rhythm and blood pressure 
pattern induced by orthostatic stress. Based on 
a modification of the original VASIS classification 
we distinguished three types of vasovagal response:
 — Mixed: heart rate falls at the time of syncope 
but the ventricular rate does not fall as low as 
40 bpm, or falls as low as 40 bpm for less than 10 s;
 — Cardioinhibition: heart rate falls to a ven-
tricular rate of 40 bpm or lower for more than 
10 s and/or there is an asystole lasting more 
than 3 s;
 — Vasodepression: heart rate does not fall more 
than 10% from its peak at the time of syncope.
For the purposes of our study the menstrual 
cycle phase was determined on the basis of the 
patient’s usual length of menstrual cycle and the 
day of the cycle on which she was tested, assuming 
constant length of the luteal phase (14 days). Pa-
tients reporting irregularity regarding the length of 
their menstrual cycle have been excluded from the 
study. Normal cycle length is considered from 21 to 
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35 days and it is an individual feature. The ovarian 
cycle consists of the follicular phase, ovulation, 
and luteal phase. The luteal phase is defined as the 
interval following but not including the luteinizing 
hormone peak (it is 24 h before ovulation) up to the 
day before menstruation. Small part of the female 
population (about 5%) has a short luteal phase 
defined as 12 days or less but the majority has 
a normal luteal phase length, which is 14.13 ± 1.41 
days [14]. We used the below formula to estimate 
the day of the menstrual cycle:
[usual length of the menstrual cycle] – 14 days = X
The day of the cycle at the moment of the HUTT 
≤ X — follicular phase
The day of the cycle at the moment of the HUTT 
> X — luteal phase
Although the normal length of the menstrual 
cycle is variable for different women (21–35 days), 
the constant length of luteal phase allows us to es-
timate with high probability the phase of menstrual 
cycle for women with regular length of menstrual 
cycle.
Ethical approval and informed consent
All procedures performed in studies involv-
ing human participants were in accordance with 
the ethical standards of the institutional and/or 
National Research Committee and with the 1964 
Helsinki declaration with its later amendments, or 
comparable ethical standards.
Informed consent was obtained from all indi-
vidual participants included in the study.
Statistical analysis
In order to assess the normal character of vari-
ables, the Kolmogorov-Smirnov test and Shapiro-
Wilk test were used. The quantitative variables 
were not normally distributed and are presented 
as medians with the IQR. Categorical variables are 
presented as percentages or frequency distribu-
tions. Data were analyzed using the Mann-Whitney 
U test. Categorical variables were analyzed using 
the c2 test. The significance threshold was set 
at p < 0.05. The analysis was conducted using 
STATISTICA software (Stat-Soft) version 10.0.
Results
Out of the 500 women enrolled in the study, 
185 (37.0%) were in menopause, 170 (34.0%) were 
in the follicular phase when tested, and 145 (29.0%) 
were in the luteal phase (NS).
The Westminster version of the passive tilt 
test was administered to 116 (23.2%) patients 
and further 79 (15.8%) patients received the 
Westminster passive protocol complemented by 
pharmacological provocation with NTG; the Ital-
ian version of the HUTT was administered to 305 
(61.0%) women. In total, NTG (provoking agent) 
was administered to 384 (78.6%) patients. There 
was no difference in either the distribution of test 
protocols or the frequency of use of pharmacologi-
cal provocation according to menopausal status or 
menstrual phase (Table 1).
The tilt test was negative in 75 (15.0%) pa-
tients, doubtful in 45 (9.0%) and positive in 380 
(76.0%) patients. In patients with a positive HUTT, 
the distribution of vasovagal responses was as 
follows: mixed: 43.8%; cardioinhibitory: 17.0% 
Table 1. Distribution of protocols used for the head-up tilt test, p = NS.
Tilt test protocol All women Post-menopausal 
women
Menstruating women
Follicular phase Luteal phase
N % N % N % N %
Westminster protocol 116 23.2 38 20.5 45 26.5 33 22.8
Westminster protocol with  
pharmacological provocation
79 15.8 16 8.6 35 20.6 28 19.3
Italian protocol 305 61.0 131 70.8 90 52.9 84 57.9
Passive standing alone 116 23.2 40 21.6 45 26.5 31 21.4
Pharmacological provocation  
with nitroglycerine
384 78.6 145 78.4 125 73.5 114 78.6
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(cardioinhibitory with asystole: 15.0%); vaso-
depressive: 15.6%. Mixed and cardioinhibitory 
responses were more frequent in pre-menopausal 
patients than post-menopausal patients (48.8% 
vs. 35.1% and 19.7% vs. 12.4%, respectively; both 
p < 0.00001), whereas vasodepressive responses 
were less frequent in pre-menopausal women 
(7.3% vs. 28.6%; p < 0.00001). Vasodepressive re-
sponses were more frequent in women in follicular 
phase than in women in the luteal phase (10.0% 
vs. 4.1%, respectively, p < 0.00001) (Table 2).
Average duration of the passive phase of the 
HUTT, duration of the pharmacological provocation 
phase, and the total test duration were similar in 
pre-menopausal and post-menopausal women, as 
well as in women in the follicular and luteal phases 
of menstrual cycle.
Mean age of the first syncope was lower in 
menstruating women (median: 15 years, IQR: 
14–56) than in post-menopausal women (median: 
30 years, IQR: 10–21; p < 0.0001).
Discussion
The main result of our study is that the preva-
lence of vasovagal syncope was similar in menstru-
ating and postmenopausal women. The important 
finding is that the type of vasovagal response to 
the orthostatic stress induced by the HUTT varied 
according to the estimated menstrual phase and 
menopausal status.
In our study, vasodepressive VVS was more 
frequent in post-menopausal women, whereas in 
menstruating women cardioinhibitory and mixed 
responses were more common. One possible expla-
nation for this observation might be the postulated 
difference in the mechanism of vasovagal syncope 
in elderly patients. In older patients, vasovagal 
syncope is sometimes called vasovagal disease. 
Most investigations into postulated pathomecha-
nisms of vasovagal syncope, such as reductions in 
sympathetic nerve activity [15], myocardial con-
tractility [16], circulating noradrenaline, renin and 
endothelin c [17] have been carried out in younger 
samples (mean age of 42.5 years) and the results 
cannot be easily generalized for the whole popula-
tion. The humoral response to orthostatic stress 
changes with age; the change is probably related to 
alterations in the autonomic nervous system. It is 
probable that in older people, the main mechanism 
for maintaining blood pressure during orthostasis 
is the sympathetic mechanism, given that plasma 
renin activity declines with age [18]. Another dif-
ference is that in the classic, isolated VVS, blood 
pressure and heart rate are constant until sudden 
drop immediately before onset of syncope, whereas 
in older patients there is a more gradual decrease 
in blood pressure [19].
As well as the difference in pathomechanism, 
the clinical pattern of VVS is also different in older 
patients. There is evidence that early onset VVS 
is different from the later onset forms, which are 
often associated with autonomic disturbances, such 
as carotid sinus hypersensitivity, post-prandial 
hypotension and other symptoms of autonomic 
dysfunction [20]. In this study, the mean age of first 
Table 2. Results of head-up tilt test (HUTT) in relation to the estimated menstrual phase and menopausal 
status.
HUTT All women Menopausal 
women
Menstruating 
women
Menstruating women
Follicular phase Luteal phase
N % N % N % N % N %
Negative result 75 15.0 25 13.5 50 15.9 33 19.4 17 11.7
Positive result 380 76.0 141 76.2 239 75.9 123 72.4 116 80.0
Doubtful result 45 9.0 19 10.3 26 8.3 14 8.2 12 8.3
Mixed response 219 43.8 65 35.1* 154 48.8* 72 42.4 82 56.6
Cardioinhibitory  
response
85 17.0 23 12.4* 62 19.7* 34 20.0 28 19.3
Without asystole 10 2.0 4 2.2 6 1.9 4 2.4 2 1.4
With asystole 75 15.0 19 10.3 56 17.8 30 17.6 26 17.9
Vasodepressive  
response
76 15.2 53 28.6* 23 7.3* 17 10.0* 6 4.1*
*p < 0.00001
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syncope was lower in menstruating patients than 
in post-menopausal patients, which may reflect 
a difference in pathology, probably related to the au-
tonomic nervous system. The observed difference 
in the prevalence of vasodepressive vasovagal re-
sponses in post-menopausal women is also consist-
ent with the majority of available evidence. Studies 
carried by Kochiadakis et al. [21] and Kurbaan et 
al. [22] show that younger people are more likely 
to show bradycardia in response to orthostatic 
stress than hypotension. Another study carried 
out on elderly population (> 65 years old) proves 
that in this group of subjects, the vasodepressor 
form of carotid sinus hypersensitivity occurs more 
often [23]. In an article on differential diagnosis of 
isolated vasovagal syndrome and vasovagal dis-
ease, Alboni et al. [20] stated that in spontaneous 
syncope, the cardioinhibitory and vasodepressive 
forms are similarly frequent.
Our finding has important therapeutic implica-
tions. The prognosis for reflex syncope is worse in 
older people due to the clinical features: prodromal 
symptoms of vasovagal syncope are often absent or 
of very short duration and therefore, injuries due 
to fainting are more likely, as is amnesia following 
the loss of consciousness, which may result in 
a misdiagnosis of unexplained falling rather than 
fainting [19, 24]. Thus, a more invasive therapy, 
including pacemaker implantation, is often consid-
ered in elderly patients, according to the European 
Society of Cardiology recommendations (IIB class 
of recommendation for HUTT-induced syncope) 
[13]. The guidelines emphasize, however, that pac-
ing is efficacious only for asystolic reflex and has 
no role in combating hypotension. This explains 
why older patients with vasodepressive VVS do 
not benefit from this kind of therapy.
Our study also revealed that the vasovagal 
mechanism differs according to the estimated 
phase of the menstrual cycle. We observed that in 
menstruating women in whom we have calculated 
the probable phase of menstrual cycle, the vasode-
pressive VVS was more frequent in the follicular 
than in the luteal phase (10% vs. 4%, respectively, 
p < 0.00001). We may try to explain this observa-
tion by the higher estrogen serum concentration 
in the follicular than in the luteal phase. Estrogens 
are responsible for increased production of nitric 
oxide, a potent vasodilator which may increase 
susceptibility to vasodepressive vasovagal syn-
cope. There are data showing that the endothelial 
hyperactivity due to upregulation of nitric oxide 
synthase is essential for regulation of vascular 
tone in VVS, and may lead to hypotension exceed-
ing the capacity of compensatory mechanisms 
[3, 4, 8]. Additionally, an increased vasoconstric-
tion, due to the noradrenaline function observed 
in the luteal phase, may inhibit vasodilatation 
provoked by orthostatic stress [25].
The difference of vasovagal mechanism re-
garding different phases of menstrual cycle is 
surprising, taking into account that most research 
indicates that although female sex hormones influ-
ence regulation of the sympathetic nervous system 
and cardiovascular system, heart rate, blood pres-
sure and orthostatic stress tolerance during the 
tilt test do not vary with menstrual phase [26, 27]. 
Meendering et al. [26] demonstrated that during 
the luteal phase of the menstrual cycle, there is 
a greater increase blood flow in the skin in response 
to elevated ambient temperature than in the fol-
licular phase. From a theoretical perspective, one 
might expect this to reduce orthostatic stress toler-
ance, however no variations in orthostatic stress 
tolerance were observed during the course of the 
menstruation cycle [26].
Previous research indicates that total pe-
ripheral resistance does not vary with hormone 
levels, despite the well-documented influence of 
estrogen and progesterone on sympathetic nerv-
ous activity [5, 28]. The evidence on changes 
in baroreflex sensitivity over the course of the 
menstrual cycle is more equivocal. The study by 
Meendering et al. [26], which was cited above, 
found that the acceleration of heart rate in re-
sponse to passive tilting did not vary according to 
phase of the menstrual cycle, which the authors 
interpreted as a lack of difference in baroreflex 
sensitivity, however another study reported that 
baroreflex sensitivity is greater in the follicular 
phase of the menstrual cycle [18]. When inter-
preting these results, it should be remembered 
that female hormones have multiple functions 
and that different paths of action may counteract 
each other. For example, estrogen which has 
a vasodilatatory effect through its effect on nitric 
oxide levels [29], may also cause an increase in 
blood plasma volume [30], thus having a bidirec-
tional effect on the blood pressure.
Another study which investigated how men-
strual cycle phase influenced the course of the 
HUTT found rather different results from ours. 
Zyśko et al. [11] have examined a group of 183 
premenopausal women. They divided menstrual 
cycle into four phases based on the self-report 
menstrual status: perimenstrual (M), preovula-
tory (F), periovulatory (O) and postovulatory (L). 
They observed that cardioinhibitory reactions were 
528 www.cardiologyjournal.org
Cardiology Journal 2017, Vol. 24, No. 5
less frequent in the post-ovulatory phase than in 
the perimenopausal and ovulatory phases [11]. 
However, it is difficult to make direct comparison 
between the studies owing to differences in how 
the menstrual cycle was divided.
Limitations of the study
The observational nature of this study consti-
tutes a limitation. We did not compare groups on 
patient characteristics other than menstrual status 
and it is possible that there are explanations for the 
observed differences between groups other than 
menstrual status.
Another limitation of our study is the lack of 
analysis of sex hormone levels on the day of the 
HUTT. Our data on menstrual phase was based 
on patients’ self-reports of standard cycle length 
and position in their cycle; we assumed a constant 
luteal phase. On the other hand, our results are 
based on a fairly large sample (301 pre-menopausal 
women), whichmakes us believe that our descrip-
tion of the influence of female sex hormones on 
the outcome of the HUTT is accurate.
Conclusions
1. Among women referred for HUTT, the preva-
lence of the VVS did not differ between those 
that were pre and post menopausal. 
2. The incidence of vasodepressive reactions 
is higher in post-menopausal women than in 
premenopausal women. 
3. In our sample, age of first syncope presenta-
tion was lower in menstruating women than 
in post-menopausal women, which may reflect 
a difference in the pathomechanism of vasovagal 
syncope (classical VVS or vasovagal disease).
4. In pre-menopausal women, vasodepressive 
VVS is more frequent in the estimated fol-
licular phase than in the luteal phase.
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